HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reduction of acute and reactivated colitis in rats by an inhibitor of neutrophil activation.

Abstract
Neutrophils have been implicated as major contributors to tissue injury in inflammatory bowel disease. In this study, we have assessed the effects of an inhibitor of neutrophil activation and adherence, NPC-18915 (4-¿2-[2-(2-benzofuranyl)phenyl]-(E)-ethenyl¿benzoic acid sodium salt), in models of both acute and reactivated colitis. Acute colitis was induced by intracolonic administration of a hapten. In other rats, colitis was reactivated 6 wk after a bout of acute colitis by subcutaneous administration of the hapten. NPC-18915 given during the first 4 days after induction of acute colitis significantly reduced tissue injury and the incidence of diarrhea and adhesions. When treatment of NPC-18915 was initiated after colitis was firmly established (48 h posthapten), it did not produce a significant effect. NPC-18915 was effective at significantly reducing colonic injury and granulocyte infiltration in the reactivated colitis model, and a similar effect could be observed in rats treated with antineutrophil serum. These results demonstrate that an inhibitor of neutrophil activation is effective in both acute and reactivated colitis, although in the former case, effectiveness is only seen when the drug is given before full establishment of colitis. These results also suggest that neutrophils, are a critical effector cell of hapten-induced colitis in the rat, particularly in the case of reactivated colitis.
AuthorsJ L Wallace, W McKnight, S Asfaha, D Y Liu
JournalThe American journal of physiology (Am J Physiol) Vol. 274 Issue 5 Pg. G802-8 (05 1998) ISSN: 0002-9513 [Print] United States
PMID9612259 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Benzoates
  • Benzofurans
  • Ferric Compounds
  • Leukotriene B4
  • NPC 18915
Topics
  • Acute Disease
  • Animals
  • Benzoates (therapeutic use)
  • Benzofurans (therapeutic use)
  • Colitis (drug therapy, physiopathology, therapy)
  • Colon (blood supply)
  • Ferric Compounds (blood, pharmacokinetics)
  • Immunization, Passive
  • Leukocyte Count (drug effects)
  • Leukotriene B4 (biosynthesis)
  • Male
  • Neutrophils (drug effects, immunology, physiology)
  • Rats
  • Rats, Wistar
  • Recurrence
  • Regional Blood Flow (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: